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The diagnosis: HTNB (OMIM 112410)
The patient has a Mendelian form of hypertension, autosomal-dominant hypertension with type E brachydactyly (HTNB). The family was aware of the diagnosis from the OMIM (112410) database (figure 2A). HTNB is a non-salt sensitive form of hypertension featuring a remarkable increase in blood pressure with increasing age amounting to about 50 mm Hg by age 50 years. 1 Untreated, HTNB results in stroke before age 50 years. Heart failure and renal failure are not common.
Gain-of-function mutations in the gene encoding phosphodiesterase 3A (PDE3A) were recently shown to cause HTNB. 1 The mutated enzyme has an enhanced cAMP-hydrolytic activity due to increased phosphorylation of two serines at positions 428 and 438 in close proximity to the mutations. We screened the highly conserved area in exon 4 of PDE3A and found that our affected family members had a mutation at glycine 449 (figure 2A). A Canadian family had a valine substitution at this point (figure 2B), whereas our family here has a novel aspartic acid substitution at this same site (p.G449D). To prove that this novel mutation also causes hyperphosphorylation we relied on a peptide SPOT assay of the PDE3A Gly449Asp mutant. Compared to wildtype peptide the mutation leads to a significantly enhanced phosphorylation at the PDE3A Ser438 residue, as we showed earlier (figure 2C and 2D). 1 HTNB was initially described in a Turkish kindred; phenotyping showed that the hypertension resembles essential hypertension, as opposed to all other Mendelian hypertensive syndromes described to date that feature increased sodium reabsorption in the distal nephron. Blood pressure lowering generally requires 2-3 different drug classes to avoid premature stroke, as underscored by our patient. Other target organs such as eye, kidney, coronaries, and heart are less affected. 2 Neurovascular contact at the rostral ventrolateral medulla and faulty baroreceptor reflex regulation are also described. Renin-angiotensincatecholamine values, acid-base regulation, and responses to provocative manoeuvres are normal in HTNB. 2 We believe that the HTNB findings are relevant to essential hypertension. First, a linkage analysis led to this locus in Chinese families with essential hypertension without a skeletal phenotype. 1,2 Second, two separate genome-wide association studies have identified PDE3A in cohorts with essential hypertension. 2, 3 Third, the PDE3 inhibitor milrinone lowers blood pressure both systemically and in the pulmonary circulation. More modest PDE3A
variation could contribute to essential hypertension. The enzyme is an attractive drug target since it is inhibited by increasing cyclic GMP and could also be addressed by specific proteinprotein interactions functioning at intracellular microdomains. 2 Physicians treating hypertension should be familiar with this syndrome. reveal a significantly increased phosphorylation of S438 of the G449D mutation (mean ± s.e.m.; biological replicates, n = 26; two-tailed students t-test, ***P < 0.001).
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